Smoflipid 20 % 1 000 ml Emulsion for intravenous infusion
PDF Leaflet Revision Date: 28 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
To supply energy and essential fatty acids when oral or enteral nutrition is impossible.
Dosage (summary)
Adults: 1-2 g fat/kg body weight/day; Infusion rate: max 0.15 g fat/kg body weight/hour.
Special Populations
- Neonates
- Elderly
- Patients with renal impairment
- Patients with liver impairment
Pregnancy & Breastfeeding
Use only after careful consideration in pregnancy and breastfeeding.
Key Drug Interactions
- Heparin may increase lipolysis
- Soybean oil contains vitamin K
Contraindications
- Hypersensitivity to components
- Severe hyperlipidaemia
- Severe liver insufficiency
- Severe renal insufficiency
- Acute shock
Common side effects
- Hypotension
- Dyspnoea
- Nausea
- Vomiting
- Slight increase in body temperature
Counselling Points
- Monitor for allergic reactions
- Avoid mixing with other medications
- Protect from light exposure in neonates
Serious warnings
- Monitor triglyceride levels
- Risk of fat overload syndrome
- Caution in impaired lipid metabolism
Important Disclaimer
The Smoflipid 20 % 1 000 ml Emulsion for intravenous infusion professional information leaflet below is the property of Fresenius Kabi South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
